spacer
home > ict > spring 2020 > the long road to esource
PUBLICATIONS
International Clinical Trials

The Long Road to eSource



Streamlining clinical research, particularly data acquisition, through the use of technology dates back to the 1990s with ‘remote data entry’, which was quickly renamed ‘electronic data capture’ (EDC) to reflect that data were being entered at investigative sites that were not ‘remote’, but rather the actual source of the data. While EDC technologies slowly gained traction, regulators were faced with the challenge of translating regulations written for paper-based processes to the new world of EDC. ‘The Final Rule for FDA Title 21, CFR Part 11: Electronic Records; Electronic Signatures’ was released in 1997 and generated numerous industry presentations, scenarios, and discussions related to the implementation of this regulation (1). Topics addressed included detailed analyses of aspects such as the source of the data, who had control of the data at a given point in the process, closed vs open systems, validation requirements, and change control procedures to maintain an audit trail. The FDA had authority to inspect these systems, and they needed to develop methods and training so that auditors could review electronic audit trails and validation documents.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author

Rebecca D Kush, PhD, is Chief Scientific Officer for Elligo Health Research, President of Catalysis Research, and Fellow for Japan’s Translational Research Innovation Center. She is the Founder and President Emeritus of CDISC, a global non-profit standard development organisation. She has over 40 years of experience in medical research and related process improvement, technology, and standards, serving on multiple boards and advisory groups. She participated in developing a consensus document on data sharing through the EU CORBEL Initiative. She earned her doctorate in Physiology and Pharmacology from UC San Diego School of Medicine, US, and a BSc in Biology and Chemistry with honours from the University of New Mexico, US.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Protagen Protein Services (PPS) expands capabilities for aggregate analytics to include dynamic light scattering (DLS)

Protein aggregation is a common challenge in the manufacturing of biological products. As one of the most sensitive techniques for the detection of aggregates, dynamic light scattering (DLS) provides a simple, fast and non-destructive testing method. An innovative technique based on a unique cuvette layout allows for accurate measurements with as little as a single µL of solution.
More info >>

White Papers

Igb Tamper Evident Folding Box

IGB

The easiest, safest and less expensive solution in compliance with what requires Dir. 62/2011/EU, FDA and TGA.
More info >>

 
Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement